Trial :

Oral drug for COVID-19 study

Age :

18 - 65 years

Trial length :

10 nights / 11 days

Info :

1 follow-up visit

We are conducting a study seeking healthy males or females, between the ages of 18 to 65 years old, who have a BMI of between 18 and 32, to participate in a Covid-19 study.

The drug will be delivered orally.

If you meet the criteria for this study and would like more information, register below or call 1800 727 874.

This study includes

Part 1 (cohorts 1, 3, 4,5, 6) : 3 nights, 4 days

2 follow up visits

Part 1 (cohort 2): 3 nights, 4 days + 3 nights, 4 days

2 follow up visits

Part 2: 14 nights, 15 days

Part 3 -  16 nights, 17 days + 1 follow up

Part 4 – 10 nights,  11 days + 1 follow up